We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
5.31%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.5M |
| 3 |
Toro Company
TTC
|
+$22.4M |
| 4 |
PepsiCo
PEP
|
+$20.4M |
| 5 |
Lockheed Martin
LMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$26.1M |
| 2 |
Wells Fargo
WFC
|
+$19.4M |
| 3 |
Centene
CNC
|
+$17.3M |
| 4 |
Eli Lilly
LLY
|
+$15.8M |
| 5 |
Kroger
KR
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.96% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Rocky Brands
RCKY
$304M
| $240K | ﹤0.01% |
17,914
+3,941
| +28% | +$52.8K |
|
|
ATYR
827
aTyr Pharma
ATYR
$46.4M
| $240K | ﹤0.01% |
+3,394
| New | +$157K |
|
|
TSC
828
DELISTED
TriState Capital Holdings, Inc.
TSC
| $240K | ﹤0.01% |
+10,461
| New | +$235K |
|
829
Stock Yards Bancorp
SYBT
$2.41B
| $239K | ﹤0.01% |
6,300
-300
| -5% | -$10.8K |
|
|
EBSB
830
DELISTED
Meridian Bancorp, Inc.
EBSB
| $239K | ﹤0.01% |
+12,800
| New | +$224K |
|
|
HIBB
831
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $237K | ﹤0.01% |
16,600
-83,541
| -83% | -$1.24M |
|
832
Photronics
PLAB
$1.79B
| $234K | ﹤0.01% |
+26,400
| New | +$234K |
|
|
MODN
833
DELISTED
MODEL N, INC.
MODN
| $233K | ﹤0.01% |
+15,580
| New | +$208K |
|
834
NVIDIA
NVDA
$5.01T
| $231K | ﹤0.01% |
+51,600
| New | +$215K |
|
835
US Bancorp
USB
$99.6B
| $229K | ﹤0.01% |
4,280
-23,100
| -84% | -$1.21M |
|
|
ICAD
836
DELISTED
iCAD Inc
ICAD
| $225K | ﹤0.01% |
50,890
+16,378
| +47% | +$62.7K |
|
|
CLUB
837
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $225K | ﹤0.01% |
+32,149
| New | +$179K |
|
|
CTIC
838
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $225K | ﹤0.01% |
70,520
+26,800
| +61% | +$89.5K |
|
839
CytomX Therapeutics
CTMX
$705M
| $223K | ﹤0.01% |
+12,250
| New | +$191K |
|
840
United Fire Group
UFCS
$1.32B
| $223K | ﹤0.01% |
4,862
-4,618
| -49% | -$200K |
|
|
ACTA
841
DELISTED
Actua Corp
ACTA
| $222K | ﹤0.01% |
+14,500
| New | +$191K |
|
842
Ardelyx
ARDX
$1.24B
| $221K | ﹤0.01% |
+39,414
| New | +$208K |
|
843
Wintrust Financial
WTFC
$10.7B
| $218K | ﹤0.01% |
2,780
| – | – |
|
844
Foster
FSTR
$443M
| $216K | ﹤0.01% |
+9,505
| New | +$185K |
|
|
LQ
845
DELISTED
La Quinta Holdings Inc.
LQ
| $216K | ﹤0.01% |
+12,340
| New | +$192K |
|
|
PAMT
846
PAMT Corp
PAMT
$340M
| $215K | ﹤0.01% |
35,996
-6,400
| -15% | -$30.4K |
|
847
Inseego
INSG
$108M
| $214K | ﹤0.01% |
14,170
+10,080
| +246% | +$129K |
|
|
RNWK
848
DELISTED
RealNetworks Inc
RNWK
| $214K | ﹤0.01% |
44,553
+1,900
| +4% | +$8.19K |
|
849
Larimar Therapeutics
LRMR
$416M
| $213K | ﹤0.01% |
5,040
+508
| +11% | +$21.1K |
|
|
FSP
850
Franklin Street Properties
FSP
$44.8M
| $211K | ﹤0.01% |
19,900
-5,500
| -22% | -$56.7K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.
- Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
- Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
- Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
- Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.